Journal article icon

Journal article

NanoBondy Reaction through NeissLock Anhydride Allows Covalent Immune Cell Decoration

Abstract:
Cell-surface conjugation has enormous therapeutic and research potential. Existing technologies for cell-surface modification are usually reversible, nonspecific, or rely on genetic editing of target cells. Here, we present the NanoBondy, a nanobody modified for covalent ligation to an unmodified protein target at the cell surface. The NanoBondy utilizes the 20 naturally occurring amino acids, harnessing NeissLock chemistry engineered from Neisseria meningitidis. We evaluated the binding and specificity of a panel of nanobodies to CD45, a long-lived surface marker of nucleated hematopoietic cells. We demonstrated the conversion of existing nanobodies to covalently reacting NanoBondies using a disulfide clamp to position the self-processing module of FrpA close to the nanobody antigen-binding site. The addition of calcium induces anhydride formation at the NanoBondy C-terminus, enabling proximity-directed ligation to surface amines on CD45. We optimized the NanoBondy reaction by fine-tuning linkers and disulfide clamp sites to modulate anhydride positioning. Tandem mass spectrometry mapped reaction sites between NanoBondy and CD45. NanoBondy ligation was robust to buffer, pH, and temperature and was detected within 2 minutes. We established the reaction specificity of NanoBondies to endogenous CD45 at the surface of NK cells and T cells. NanoBondy technology provides a modular approach for targeted, inducible, and covalent cell-surface modification of immune cells without their genetic modification.
Publication status:
Published
Peer review status:
Peer reviewed

Actions

Access Document

Publisher copy:
10.1021/acs.bioconjchem.5c00519

Authors

More by this author
Institution:
University of Oxford
Division:
MSD
Department:
Pathology Dunn School
Sub department:
Pathology Dunn School
Role:
Author
More by this author
Role:
Author
ORCID:
0000-0001-7390-501X
More by this author
Institution:
University of Oxford
Division:
MSD
Department:
Biochemistry
Sub department:
Biochemistry
Role:
Author
ORCID:
0000-0002-2606-9220
More by this author
Institution:
University of Oxford
Division:
MSD
Department:
Pathology Dunn School
Sub department:
Pathology Dunn School
Role:
Author
More by this author
Institution:
University of Oxford
Division:
MSD
Department:
Pathology Dunn School
Sub department:
Pathology Dunn School
Role:
Author


More from this funder
Funder identifier:
https://ror.org/0439y7842
Grant:
EP/T022159/1
More from this funder
Funder identifier:
https://ror.org/00cwqg982
Grant:
BB/R000344/1
More from this funder
Funder identifier:
https://ror.org/029chgv08
Grant:
207537/Z/17/Z
More from this funder
Funder identifier:
https://ror.org/057g20z61


Publisher:
American Chemical Society
Journal:
Bioconjugate Chemistry More from this journal
Volume:
37
Issue:
2
Pages:
281-292
Publication date:
2026-01-24
Acceptance date:
2025-12-15
DOI:
EISSN:
1520-4812
ISSN:
1043-1802


Language:
English
Keywords:
Pubs id:
2365413
Local pid:
pubs:2365413
Source identifiers:
3777114
Deposit date:
2026-02-19
ARK identifier:
This ORA record was generated from metadata provided by an external service. It has not been edited by the ORA Team.

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP